Literature DB >> 6120139

Heterozygote detection in MLD. allelic mutations at the ARA locus.

D F Farrell.   

Abstract

The detection of heterozygotes for MLD based on enzyme assays of a general population is highly unreliable. Twenty-three percent of controls and ARA activities below the levels found in some obligate heterozygotes for MLD. This serious overlap problem precludes the use of ARA determinations in large screening programs to assign individuals into specific genetic categories. On the other hand, intrafamily analysis of ARA activity offers the possibility of accurately determining heterozygotes for MLD. Sixteen children of parents heterozygous for MLD had ARA activities which clearly categorized them as either homozygous affected, heterozygous, or normal. The wide range of ARA activity found in controls and heterozygotes for MLD appeared to result from the presence of multiple allelic mutations at the ARA locus. One of these mutations leads to a low ARA activity and when present in an individual who is heterozygous for MLD may lead to overlap of his total activity with that of some homozygous affected individuals. This low ARA activity mutation can be recognized by alterations in the multiple molecular forms of ARA activity separated by analytical isoelectric focusing electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6120139     DOI: 10.1007/bf00293061

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  40 in total

1.  The nature of the residual arylsulfatase activity in metachromatic leukodystrophy.

Authors:  E Shapira; H L Nadler
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

2.  Letter: Absence of ASA activity in healthy father of a patient with metachromatic leukodystrophy.

Authors:  G Dubois; J C Turpin; N Baumann
Journal:  N Engl J Med       Date:  1975-08-07       Impact factor: 91.245

3.  Cerebroside sulfate hydrolysis by fibroblasts from a parent with metachromatic leukodystrophy.

Authors:  A L Fluharty; R L Stevens; H Kihara
Journal:  J Pediatr       Date:  1978-05       Impact factor: 4.406

4.  Inheritance of metachromatic leukodystrophy.

Authors:  U Langenbeck; P Dunker; R Heipertz; H Pilz
Journal:  Am J Hum Genet       Date:  1977-11       Impact factor: 11.025

5.  The use of biochemical data in screening for mutant alleles and in genetic counselling.

Authors:  R J Gold; U R Maag; J L Neal; C R Scriver
Journal:  Ann Hum Genet       Date:  1974-01       Impact factor: 1.670

6.  A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy.

Authors:  M T Porter; A L Fluharty; J Trammell; H Kihara
Journal:  Biochem Biophys Res Commun       Date:  1971-08-06       Impact factor: 3.575

7.  Multiple molecular forms of arylsulfatase A in different forms of metachromatic leukodystrophy (MLD).

Authors:  D F Farrell; M P MacMartin; A F Clark
Journal:  Neurology       Date:  1979-01       Impact factor: 9.910

8.  Antenatal diagnosis of Krabbe's leucodystrophy: enzymatic and morphological confirmation in an affected fetus.

Authors:  D F Farrell; S M Sumi; C R Scott; G Rice
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-01       Impact factor: 10.154

9.  Purification and properties of arylsulfatase. A from human urine.

Authors:  R L Stevens; A L Fluharty; M H Skokut; H Kihara
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

10.  Metachromatic leukodystrophy in the habbanite Jews: high frequency in a genetic isolate and screening for heterozygotes.

Authors:  J Zlotogora; G Bach; Y Barak; E Elian
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

View more
  1 in total

1.  Population carrier rates of pathogenic ARSA gene mutations: is metachromatic leukodystrophy underdiagnosed?

Authors:  Agnieszka Ługowska; Joanna Ponińska; Paweł Krajewski; Grażyna Broda; Rafał Płoski
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.